An Observational Study of the Safety of Herceptin Given Subcutaneously in Patients With Early HER2-positive Breast Cancer
Clinical trial NCT02286362 · COMPLETED
Trial details
- NCT number
- NCT02286362
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-01-14
- Primary completion
- 2016-11-10
- Enrollment
- 510
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.